Wealthfront Advisers LLC Has $9.75 Million Holdings in Centene Corporation $CNC

Wealthfront Advisers LLC increased its holdings in shares of Centene Corporation (NYSE:CNC) by 309.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 273,177 shares of the company’s stock after purchasing an additional 206,387 shares during the quarter. Wealthfront Advisers LLC owned approximately 0.06% of Centene worth $9,747,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of CNC. ProShare Advisors LLC increased its position in shares of Centene by 13.0% in the third quarter. ProShare Advisors LLC now owns 129,081 shares of the company’s stock valued at $4,606,000 after acquiring an additional 14,815 shares during the last quarter. Linden Thomas Advisory Services LLC grew its stake in Centene by 8.8% in the third quarter. Linden Thomas Advisory Services LLC now owns 17,222 shares of the company’s stock valued at $614,000 after purchasing an additional 1,390 shares in the last quarter. Oppenheimer Asset Management Inc. increased its position in shares of Centene by 46.3% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 260,412 shares of the company’s stock worth $9,292,000 after purchasing an additional 82,354 shares during the last quarter. RFG Advisory LLC boosted its holdings in shares of Centene by 19.0% in the 3rd quarter. RFG Advisory LLC now owns 15,342 shares of the company’s stock valued at $547,000 after buying an additional 2,448 shares during the last quarter. Finally, Smartleaf Asset Management LLC grew its stake in shares of Centene by 32.2% in the third quarter. Smartleaf Asset Management LLC now owns 2,317 shares of the company’s stock valued at $82,000 after buying an additional 565 shares in the last quarter. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Centene Trading Up 2.1%

CNC stock opened at $40.43 on Thursday. Centene Corporation has a 52 week low of $25.08 and a 52 week high of $66.03. The company has a market capitalization of $19.87 billion, a PE ratio of -2.97, a price-to-earnings-growth ratio of 0.87 and a beta of 0.48. The company’s 50-day simple moving average is $42.08 and its 200 day simple moving average is $36.18. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.08 and a current ratio of 1.10.

Centene (NYSE:CNC) last posted its quarterly earnings data on Friday, February 6th. The company reported ($1.19) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.22) by $0.03. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. The firm had revenue of $49.73 billion during the quarter, compared to the consensus estimate of $48.41 billion. During the same quarter in the previous year, the firm posted $0.80 EPS. The business’s revenue for the quarter was up 21.9% compared to the same quarter last year. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. As a group, sell-side analysts anticipate that Centene Corporation will post 6.86 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages have commented on CNC. Argus upgraded shares of Centene to a “hold” rating in a research note on Monday. Weiss Ratings reissued a “sell (d)” rating on shares of Centene in a research report on Wednesday, January 21st. UBS Group set a $42.00 target price on Centene and gave the stock a “neutral” rating in a research note on Thursday, October 30th. JPMorgan Chase & Co. increased their price target on Centene from $38.00 to $45.00 and gave the company a “neutral” rating in a research note on Thursday, January 22nd. Finally, Zacks Research raised shares of Centene from a “strong sell” rating to a “hold” rating in a research report on Wednesday, October 29th. Three investment analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, Centene presently has a consensus rating of “Hold” and a consensus target price of $41.50.

Centene News Summary

Here are the key news stories impacting Centene this week:

• Positive Sentiment: Deutsche Bank raised its price target to $39 (from $32) while keeping a “hold” rating — the PT bump improves near‑term sentiment and likely helped buying interest. Deutsche Bank Boosts PT to $39
• Positive Sentiment: TD Cowen raised its price target to $38 (maintaining a “hold”) — another upward revision that supports investor confidence even if the rating stays neutral. TD Cowen Raises PT to $38
• Positive Sentiment: Media/analyst write‑ups (Zacks/MSN) profile Centene as a long‑term value stock — such coverage can attract buy‑and‑hold investors and bolster demand. Zacks: Top Value Stock
• Neutral Sentiment: Cantor Fitzgerald reaffirmed a “neutral” rating, leaving analyst guidance unchanged. Cantor Fitzgerald Reaffirms Neutral
• Neutral Sentiment: Argus and Morgan Stanley maintained “hold/neutral” stances — multiple holds suggest limited near‑term upside from analyst action alone. Argus Upgrade to Hold Morgan Stanley Maintains Hold
• Neutral Sentiment: Superior HealthPlan (a Centene company) launched a school program addressing social isolation — positive PR/ESG impact but unlikely to move near‑term earnings. PR: No One Eats Alone
• Negative Sentiment: Axios reports Centene is among insurers to receive subpoenas from a House panel — this introduces regulatory and legal risk that could weigh on the stock if the inquiry deepens. Axios: House Panel Subpoenas

Centene Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.